June 5, 2017 | Israeli startup Belkin Laser, a portfolio company of Israel’s RAD Biomed accelerator, has secured $5 million in funding from Zicom Holdings, Rimonci Capital and the European Union (grant). The capital raised adds to the $1.5 million previously raised by the company. Belkin Laser develops a laser device for glaucoma patients who will receive short, efficient treatments, instead of the eye drops used today. Belkin Laser was founded in 2013 under a license agreement from Israel’s Sheba Medical Center and Tel Aviv University. Its product is based on Prof. Michael Belkin’s invention. [Photo: TobiasD]
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Top European Carmakers To Include Israeli Chipset In New Vehicles
September 18, 2024
Sheba Named As One Of World's Top 10 Smart Hospitals
September 18, 2024
New AI-Powered Robot Specializes In Picking Citrus Fruit
September 17, 2024
Researchers Develop New Early Identification For Parkinson’s
September 16, 2024
Facebook comments